With our SEAS technology, we can simulate the various risk-return payoffs, future scenarios on likely introduction of a drug or expiration of a patent. Implementation for any marketing plan, merger, take-over, price cuts or R&D investment can be achieved in virtual space.
Intelligent agents can represent small, medium, and larger pharmaceutical firms. Each simulation can be customized as per client specifications.
In addition to its commercial enterprises, Simulex is an active member of the academic community and a frequent contributor of original research publications in the fields of distributed computing, artificial intelligence, agent-based synthetic environments, experimental economics, and various disciplines of management science.
Publications can be viewed by request.